Complications with glutaraldehyde-preseved bioprostheses

Area of Science:

• Cardiovascular Surgery
• Biomaterials Science
• Clinical Outcomes Research

Background:

• Bioprosthetic heart valves offer an alternative to mechanical valves.
• Glutaraldehyde preservation is a common method for tissue valve treatment.
• Assessing long-term outcomes of glutaraldehyde-preserved valves is crucial for surgical practice.

Purpose of the Study:

• To evaluate the early and late outcomes of glutaraldehyde-preserved bioprosthetic valve implantation.
• To identify the incidence of complications such as thromboembolism, valve incompetence, and structural failure.
• To assess the safety and efficacy of these bioprostheses in aortic and mitral positions.

Main Methods:

• A retrospective analysis of 184 glutaraldehyde-preserved valve bioprostheses implanted between May 1975 and May 1979.
• Patient data included demographics, pre-existing conditions, surgical procedures, and post-operative follow-up.
• Complications such as thromboembolism, valve incompetence, stenosis, and endocarditis were recorded.

Main Results:

• Four early deaths occurred in aortic valve replacement patients, associated with coronary artery disease.
• One late death from endocarditis in the aortic group; three early and two late deaths in the mitral group.
• Seven instances of significant thromboembolism and nine of valve incompetence, including five mitral periprosthetic leaks requiring reoperation.
• Three cases of mitral prosthesis stenosis; no intrinsic leaflet incompetence was observed.

Conclusions:

• Glutaraldehyde-preserved bioprosthetic valves demonstrate acceptable early and late performance.
• Thromboembolism and paravalvular leaks are significant complications requiring monitoring and potential intervention.
• The absence of intrinsic leaflet incompetence suggests durability of the glutaraldehyde preservation method.